Petredis Investment Advisors »

SPDR S&P Biotech shares owned by Petredis Investment Advisors

Quarter-by-quarter ownership of SPDR S&P Biotech (XBI) shares owned by Petredis Investment Advisors from 13F filings

Historical chart of Petredis Investment Advisors investment in SPDR S&P Biotech

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Biotech held by Petredis Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Biotech by Petredis Investment Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $5.2M 55k 94.89
2023-09-30 $4.0M 55k 73.02
2023-06-30 $4.6M 55k 83.20
2023-03-31 $4.2M 55k 76.21
2022-12-31 $4.5M 55k 83.00

More positions owned by Petredis Investment Advisors

Select Sector Spdr Tr Financial (XLF)
Vanguard World Mega Grwth Ind (MGK)
Microsoft Corporation (MSFT)
Vanguard World Mega Cap Val Etf (MGV)
NVIDIA Corporation (NVDA)
Select Sector Spdr Tr Technology (XLK)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Admiral Fds 500 Val Idx Fd (VOOV)
Amazon (AMZN)
Meta Platforms Cl A (META)
UnitedHealth (UNH)
Select Sector Spdr Tr Communication (XLC)
Costco Wholesale Corporation (COST)
Advanced Micro Devices (AMD)

View all positions for Petredis Investment Advisors

Top funds holding SPDR S&P Biotech

Goldman Sachs Group
Citadel Advisors
Millennium Management
UBS Group
Bank of America Corporation
Citigroup
venBio Select Advisor
Jpmorgan Chase & Co
Nantahala Capital Management
Healthcare Of Ontario Pension Plan Trust Fund
Moore Capital Management
Barclays
Perceptive Advisors
Gts Securities
Brown Advisory Holdings Incorporated

View all funds holding SPDR S&P Biotech